Investigation of the effects of eflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates;Yüksek düzey florokinolon dirençli Escherichia coli klinik izolatlarinda efluks pompa inhibitörlerinin siprofloksasin MIK deǧerleri üzerine etkilerinin araştrilmasi

Mikrobiyoloji Bulteni

Volumn 38, Issue 1-2, 2004, Pages 21-25

  Çoban, Ahmet Yilmaz ^a   Birinci, Asuman ^a   Ekinci, Bora ^a   Durupinar, Belma ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

110; Efflux pump; Escherichia coli; Lansoprazole; MC 207; Omeprazole; Verapamil

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CIPROFLOXACIN; DIPEPTIDE; DRUG DERIVATIVE; ENZYME INHIBITOR; LANSOPRAZOLE; OMEPRAZOLE; PHENYLALANINE ARGININE BETA NAPHTHYLAMIDE; PHENYLALANINE ARGININE BETA-NAPHTHYLAMIDE; VERAPAMIL;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIURIA; DRUG EFFECT; DRUG INTERACTION; ESCHERICHIA COLI; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-INFECTIVE AGENTS; BACTERIURIA; CALCIUM CHANNEL BLOCKERS; CIPROFLOXACIN; DIPEPTIDES; DRUG INTERACTIONS; DRUG RESISTANCE, BACTERIAL; ENZYME INHIBITORS; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; OMEPRAZOLE; VERAPAMIL;

EID: 28744455680     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Paulsen IT, Brown MH, Skurray RA: Proton-dependent multidrug efflux systems. Microbiol Rev 1996, 60: 575-608.
2. Poole K: Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrob Agents Chemother 2000, 44: 2233-2241.
3. Mazzariol A, Tokue Y, Kanegawa TM, Cornaglia G, Nikaido H: High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother 2000, 44: 3441-3443.
4. Oethinger M, Kern WV, Jellen-Ritter AS, McMurray LM, Levy SB: Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 2000, 44: 10-13.
5. Van Bambeke F, Glupczynski Y, Plesiat P, Pechere JC, Tulkens PM: Antibiotic efflux pumps in prokaryotic cells: Occurrence, impact on resistance and strategies for the future of antimicrobial therapy J Antimicrob Chemother 2003, 51: 1055-1065.
6. Webber MA, Piddock LJV: The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003, 51: 9-11.
7. Lomovskaya O, Warren MS, Lee A, et al: Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: Novel agents for combination therapy. Antimicrob Agents Chemother 2001, 45: 105-116.
8. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A5. 2000, NCCLS, Wayne, PA.
9. Ribera A, Ruiz J, de Anta MTJ, Vila J: Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates. J Antimicrob Chemother 2002, 49: 697-702.
10. Çoban AY, Ekinci B, Durupinar B: A multidrug efflux pump inhibitor reduces fluoroquinolones resistance in Pseudomonas aeruginosa isolates. Chemotherapy (Baskida).
11. Sanchez P, Le U, Martinez JL: The efflux pump inhibitor Phe-Arg-b-naphthylamide does not abolish the activity of the Stenotrophomonas maltophilia SmeDEF multidrug efflux pump. J Antimicrob Chemother 2003, 51: 1042-1045.
12. Choudhuri BS, Bhakta S, Barik R, Basu J, Kundu M, Chakrabarti P: Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes ddrA and drrB of Mycobacterium tuberculosis. Biochem J 2002, 367: 279-285.
13. Silva PE, Bigi F, de la Paz Santangelo M, Romano MI, et al: Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob Agents Chemother 2001, 45:800-804.
14. Çoban AY, Durupinar B: Florokinolonlara dirençli Pseudomonas aeruginosa suşlannda verapamilin direnç inhibisyonuna etkisinin araştirilmasi. İnfeks Derg 2003, 17: 201-203.